Atlas Trials

Role of Hemostatic Powder (Endo-clotTM) in Prevention of Bleeding Within High Risk Patients After ESD

Clinical trial NCT02625792 · COMPLETED

Trial details

NCT number
NCT02625792
Sponsor
Yonsei University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Iatrogenic Ulcer After ESD
Start date
2015-12-01
Primary completion
2016-10-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.